Clinical Trials
4 trialsNCT07210047 2025-10-07
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
HuniLife Biotechnology, Inc.
Phase 1/2 Enrolling by invitation
NCT07014462 2025-10-06
DLIT-AML
University of Vermont
Phase 1 Enrolling by invitation
NCT07016737 2025-06-12
ESO-Nanjing12
Jiangsu Cancer Institute & Hospital
Phase 3 Enrolling by invitation
NCT03815279 2019-08-16
iStopMM
Landspitali University Hospital
Phase 2 Enrolling by invitation